Research Analysts' Weekly Ratings Updates for Collegium Pharmaceutical (COLL)
Collegium Pharmaceutical (NASDAQ: COLL) recently received a number of ratings updates from brokerages and research firms: 4/11/2022 – Collegium Pharmaceutical was downgraded by analysts at TheStreet from a “b-” rating to a “c+” rating. 4/6/2022 – Collegium Pharmaceutical had its price target raised by analysts at Needham & Company LLC from $34.00 to $36.00. They […]